On May 9, 2025, the President issued Executive Order (“E.O.”) 14294, Fighting Overcriminalization in Federal Regulations. 90 FR 20363 (published May 14, 2025). Section 7 of E.O. 14294 provides that within 45 days of the order, and in consultation with the Attorney General, each agency should publish guidance in the Federal Register describing its plan to address criminally liable regulatory offenses.

Consistent with that requirement, USDA advises the public that by May 9, 2026, the Department, in consultation with the Attorney General, will provide to the Director of the Office of Management and Budget (“OMB”) a report containing: (1) a list of all criminal regulatory offenses  1 enforceable by USDA or the Department of Justice (“DOJ”); and (2) for each such criminal regulatory offense, the range of potential criminal penalties for a violation and the applicable mens rea standard  2 for the criminal regulatory offense.

This notice also announces a general policy, subject to appropriate exceptions and to the extent consistent with law, that when USDA is deciding whether to refer alleged violations of criminal regulatory offenses to DOJ, officers and employees of USDA should consider, among other factors:

• The harm or risk of harm, pecuniary or otherwise, caused by the alleged offense;

• The potential gain to the putative defendant that could result from the offense;

• whether the putative defendant held specialized knowledge, expertise, or was licensed in an industry related to the rule or regulation at issue; and

• Evidence, if any is available, of the putative defendant's general awareness of the unlawfulness of his conduct as well as his knowledge or lack thereof of the regulation at issue.

Consistent with E.O. 14294 and the general policy set forth above, the following actions shall be undertaken:

a. Within 90 days of publication of this notice, each agency shall review its regulations and submit to the Office of the General Counsel a list of all criminal regulatory offenses enforceable by the agency or the DOJ and describe the applicable statutory authorities, the range of potential criminal penalties for a violation, and the applicable mens rea standard for the criminal regulatory offense;

b. Within 120 days of publication of this notice, each agency shall review its directives and other internal guidance documents and submit to the Office of the General Counsel a list of directives and guidance documents that may not be consistent with E.O. 14294 and the general policy set forth above;

c. Within 180 days of publication of this notice, the Office of the General Counsel shall make recommendations to the Secretary on actions to further the intent of E.O. 14294 and the general policy set forth above.

This general policy is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person.

The Census Bureau's Freedom of Information Act (FOIA) Office receives an estimated 250 Privacy Act requests annually. In order to protect the public's privacy and adhere to Privacy regulations, the Census Bureau's FOIA Office developed the Certification of Identity (Form BC-300) to assist with accurately identifying and providing personnel records to requesters. The Form BC-300 asks requesters to provide general information such as name, address, date of birth (D.O.B), description of the request, etc. The form provides added protection in managing sensitive records regulated under the Privacy Act. This form will be hosted by the Census Bureau as a Common Form.

The Privacy Act of 1974 (the Privacy Act), as amended, 5 U.S.C. 552a, establishes a code of fair information practices that governs the collection, maintenance, use, and dissemination of information about individuals that is maintained in systems of records by federal agencies. Regulations at 15 CFR part 4, subpart B prescribe how an individual must make a request for access to his or her own personal records to the Census Bureau under the Privacy Act. Generally, one may submit a request for access to his or her own personal records by appearing in person, electronically through the FOIA public website, or by writing to the Census FOIA Office. The regulations require that the requestor describe the records in enough detail to enable Census Bureau personnel to locate the applicable system of records containing the information with a reasonable amount of effort. 15 CFR 4.4(c). A request made under the Privacy Act should include the information listed at 15 CFR 4.24(b), including whenever possible, a description of the records sought, the time periods they were compiled, and the name or identifying number of each system of records where they are kept. Furthermore, requestor must provide documentation or proof of identity. 15 CFR 4.24(d). These documents include information such as the requestor's full name, current address, D.O.B, and place of birth, and where required, a notarized or sworn statement of identity. All Privacy Act requests not made in person must contain a verification of identity that either is notarized or signed under penalty of perjury. 15 CFR 4.24(d). The Census Bureau is prohibited by Federal law from disclosing any information contained in the records, except upon written request from the person to whom the information pertains or to a legal representative.

The Form BC-300 is used to collect general information in order to sufficiently identify a respondent to ensure accurate records are provided to the right person as stated in 15 CFR 4.24(d). The Form BC-300 asks for name, address, D.O.B., description of request, and signature, in accordance with 15 CFR 4.24(d). The form explains the purpose and includes the Privacy Act Statement, the disclosure statement, the authorities under which the Census Bureau is authorized to collect the information, and an explanation of burden to the requester. The Form BC-300 is a “public use” form meaning that this form is used for all public and internal agency requests for personal records.

The Form BC-300 is available in both printable and electric formats. The online fillable version helps minimize the requester's processing time for filling out and submitting the form. The Census Bureau will receive all Form BC-300s either electronically submitted through the Census FOIA website, by fax, or via postal mail. In all circumstances, proper identification of the requestor must be obtained to ensure distribution of accurate records to the correct individuals. Providing this information is voluntary; however, if not provided, the Census Bureau will be unable to provide the requested personal records.

OMB Control Number: 0607-1018.

Form Number(s): Form BC-300, Common Form.

Type of Review: Regular submission, Request for an Extension without change of a currently approved collection.

Affected Public: Individuals requesting the release of his or her own records.

Estimated Number of Respondents: 400 (annual respondents).

Estimated Time per Response: 6 minutes.

Estimated Total Annual Burden Hours: 40.

Estimated Total Annual Cost to Public: $0 (This is not the cost of respondents' time, but the indirect costs respondents may incur for such things as purchases of specialized software or hardware needed to report, or expenditures for accounting or records maintenance services required specifically by the collection.)

Respondent's Obligation: Voluntary.

Legal Authority: In accordance with 15 CFR part 4, subpart B, the U.S. Census Bureau requires the submission of sufficient information to identify individuals that submit requests by mail or otherwise not in person under the Privacy Act of 1974, 5 U.S.C. 552a.

We are soliciting public comments to permit the Department/Bureau to: (a) Evaluate whether the proposed information collection is necessary for the proper functions of the Department, including whether the information will have practical utility; (b) Evaluate the accuracy of our estimate of the time and cost burden for this proposed collection, including the validity of the methodology and assumptions used; (c) Evaluate ways to enhance the quality, utility, and clarity of the information to be collected; and (d) Minimize the reporting burden on those who are to respond, including the use of automated collection techniques or other forms of information technology.

Comments that you submit in response to this notice are a matter of public record. We will include, or summarize, each comment in our request to OMB to approve this ICR. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you may ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so.

The Federal Register citation for the final results of the United States International Trade Commission's 5-Year Review of the Large Diameter Welded Pipe from Canada Antidumping Order is May 2, 2025 (90 FR 18867).

Article 10.12 of Chapter 10 of USMCA provides a dispute settlement mechanism involving trade remedy determinations issued by the Government of the United States, the Government of Canada, and the Government of Mexico. Following a Request for Panel Review, a Binational Panel is composed to review the trade remedy determination being challenged and issue a binding Panel Decision. There are established USMCA Rules of Procedure for Article 10.12 (Binational Panel Reviews), which were adopted by the three governments for panels requested pursuant to Article 10.12(2) of USMCA which requires Requests for Panel Review to be published in accordance with Rule 40. For the complete Rules, please see https://can-mex-usa-sec.org/secretariat/agreement-accord-acuerdo/usmca-aceum-tmec/rules-regles-reglas/article-article-articulo_10_12.aspx?lang=eng.

The Rules provide that:

(a) A Party or interested person may challenge the final determination in whole or in part by filing a Complaint in accordance with Rule 44 no later than 30 days after the filing of the first Request for Panel Review (the deadline for filing a Complaint is June 30, 2025);

(b) A Party, an investigating authority or other interested person who does not file a Complaint but who intends to participate in the panel review shall file a Notice of Appearance in accordance with Rule 45 no later than 45 days after the filing of the first Request for Panel Review (the deadline for filing a Notice of Appearance is July 14, 2025);

(c) The panel review will be limited to the allegations of error of fact or law, including challenges to the jurisdiction of the investigating authority, that are set out in the Complaints filed in the panel review and to the procedural and substantive defenses raised in the panel review.

Authority: 15 U.S.C. 3711a(d)(1); 15 U.S.C. 3711a(d)(2)(B); and the Federal Advisory Committee Act, as amended, 5 U.S.C. 1000 et seq.

Pursuant to the Federal Advisory Committee Act, as amended, 5 U.S.C. 1000 et seq., notice is hereby given that the Board of Overseers will meet in open session on Wednesday, June 25, 2025, from 11 a.m. eastern time until 4 p.m. eastern time. The Board is composed of approximately six members preeminent in the field of organizational performance excellence and appointed by the Secretary of Commerce, makes an annual report on the results of Award activities to the Director of the National Institute of Standards and Technology (NIST), along with its recommendations for improvement of the Award process. The Board consists and includes members familiar with the quality, performance improvement operations, and competitiveness issues of a balanced representation from U.S. service, manufacturing, nonprofit, education, and healthcare industries.

The purpose of this meeting is to welcome and introduce the Board and to review and discuss the work of the Baldrige Performance Excellence Program (“Program”). The agenda will include the Baldrige Program Update, Baldrige Foundation Update, Judges Panel of the Malcolm Baldrige National Quality Award Update (“Judges Panel”) Update, Ethics Review for both the Judges Panel and the Board, Alliance for Performance Excellence Update, Communities of Excellence Update, and New Business/Public Comment. The agenda may change to accommodate the Board of Overseers business. The final agenda will be posted on the NIST Baldrige Performance Excellence website at https://www.nist.gov/baldrige/community/overseers.cfm. The meeting is open to the public.

Individuals and representatives of organizations who would like to offer verbal comments and suggestions related to the Board's affairs are invited to request a place on the agenda. Approximately one half hour will be reserved for public comments during the June 25th meeting, and speaking times will be assigned on a first-come, first-served basis. The amount of time per speaker will be determined by the number of requests received but is likely to be about three minutes each. The exact time for public comments will be included in the final agenda that will be posted on the Baldrige Performance Excellence Program website at https://www.nist.gov/baldrige/community/overseers.cfm. Questions from the public will not be considered during this period. Requests must be submitted by email to Robyn Decker at robyn@nist.gov and must be received by 4 p.m. eastern time, June 20, 2025, to be considered. Speakers who wish to expand upon their oral statements, those who had wished to speak but could not be accommodated on the agenda, and those who were unable to attend in person are invited to submit written statements by email to robyn@nist.gov. Written statements may be submitted at any time.

Admittance instructions: All participants will be attending virtually via webinar and need to pre-register to be admitted. Please contact Mrs. Robyn Decker by email at robyn@nist.gov; Mailing Address: NIST c/o Robyn Decker 100 Bureau Drive, MS 1020 Gaithersburg, MD 20899; or 301-975-2361, please provide her with your name, email, and phone number; and she will provide you with instructions for webinar admittance. All requests to attend must be received by 4 p.m. eastern time, June 17, 2025.

Special Accommodations: Individuals requiring special accommodations to access the public meeting should contact robyn@nist.gov, no later than June 17, 2025, so that appropriate arrangements can be made.

Authority: The ISPAB was established to function solely as an advisory body, in accordance with the provisions of the Federal Advisory Committee Act, as amended, 5 U.S.C. 1001 et seq. The Board reports to the Director of NIST, and reports annually to the Secretary of Commerce, the Secretary of Homeland Security, the Director of the Office of Management and Budget, the Director of the National Security Agency, and appropriate committees of Congress. The Board is authorized under 15 U.S.C. 278g-4 and tasked with identifying emerging managerial, technical, administrative, and physical safeguard issues relative to information security and privacy.

Pursuant to the Federal Advisory Committee Act, as amended, 5 U.S.C. 1001 et seq., notice is hereby given that the ISPAB will hold an open meeting on the date and time in the DATES section and will be open to the public. primary purpose of this meeting is to discuss and deliberate potential recommendations. The agenda may change to accommodate ISPAB business. The final agenda will be posted on the NIST website at https://csrc.nist.gov/Events/2025/ispab-july-2025-meeting and is expected to include the following items:

Individuals and representatives of organizations who would like to offer comments and suggestions related to the Board's business are invited to request a place on the agenda. Approximately thirty minutes will be reserved for public comments and speaking times will be assigned on a first-come, first-serve basis. The amount of time per speaker will be determined by the number of requests received but is likely to be about five minutes each. Questions from the public will not be considered during this period. Speakers who wish to expand upon their oral statements, those who had wished to speak but could not be accommodated on the agenda, and those who were unable to participate are invited to submit written statements by email to jeffrey.brewer@nist.gov .

All participants will be attending via webinar and are required to pre-register to be admitted to the meeting. To register and receive detailed instruction on how to join the meeting, please submit your first and last name, email address, and company name via the registration link at https://csrc.nist.gov/Events/2025/ispab-july-2025-meeting by 5 p.m. Eastern Time, Monday, July 14, 2025.

Title; Associated Form; and OMB Number: Reserve Component Spouse Survey; OMB Control Number 0704-0653.

Needs and Uses: The DoD Survey of Reserve Component Spouses is the primary source for reliable and generalizable data on the effects of military life on military spouses and their families and the impact of military life on Reserve component war fighter readiness and retention. This data provides vital information on the need for programs and policies under the purview of DoD's Military Community and Family Policy Department. Without this biennial survey, DoD would not have current data to guide limited resources to the appropriate programs, policies, and services related to reserve component spouses, their families, and service members.

This survey provides an opportunity for military spouses to directly expand policy maker's knowledge by sharing their experiences and opinions on issues that directly affect them. Success of current efforts, the impact of activations and deployments, and opportunities to identify areas of need are captured via this biennial survey. These survey results ensure that policy-making decisions are based on current and statistically reliable data regarding the lived experiences of Reserve component families.

The legislation authorizing the USD(P&R) to conduct these surveys is provided under 10 United States Code (U.S.C.), Sections 136, 1782 and 2358, and 37 U.S.C., Section 1008(b).

Affected Public: Individuals or households.

Annual Burden Hours: 8,900.

Number of Respondents: 17,800.

Responses per Respondent: 1.

Annual Responses: 17,800.

Average Burden per Response: 30 minutes.

Frequency: Biennially.

We are correcting the May 16, 2025, NIA to remove the statement that no more than 5 percent of grant funds may be used for direct administration of the grant project because, as stated in another section of the NIA, the program does not include any program-specific limitation on administrative expenses.

In FR Doc. No. 2025-08766, in the Federal Register published on May 16, 2025 (90 FR 21021), we make the following correction:

On Page 21026, in the first column, under the heading 4. Funding Restrictions, revise the last paragraph in this section to remove the statement, “In accordance with section 437(d)(1) of GEPA, 20 U.S.C. 1232(d)(1), we establish that no more than 5 percent of grant funds may be used for direct administration of the grant project.” This correction is necessary to clarify that the program does not impose specific limits on administrative expenses.

Program Authority: Title IV, part C of the ESEA, as amended.

Accessible Format: On request to the contact person listed under FOR FURTHER INFORMATION CONTACT , individuals with disabilities can obtain this notice, the NIA, and a copy of the application in an accessible format. The Department will provide the requestor with an accessible format that may include Rich Text Format (RTF) or text format (txt), a thumb drive, an MP3 file, braille, large print, audiotape, or compact disc, or other accessible format.

Electronic Access to This Document: The official version of this document is the document published in the Federal Register . You may access the official edition of the Federal Register and the Code of Federal Regulations at www.govinfo.gov. At this site you can view this document, as well as all other documents of this Department published in the Federal Register , in text or Portable Document Format (PDF). To use PDF you must have Adobe Acrobat Reader, which is available free at the site.

You may also access documents of the Department published in the Federal Register by using the article search feature at: www.federalregister.gov. Specifically, through the advanced search feature at this site, you can limit your search to documents published by the Department.

This is a summary of CGB's document, CG Docket No. 25-165; DA 25-376, released on May 2, 2025. The full text of this document, including instructions on how to file comments; the spreadsheet associated with document DA 25-376 listing the proceedings proposed for termination; and copies of any subsequently filed documents in this matter will be available for public inspection and copying via ECFS at: https://www.fcc.gov/ecfs/. Document DA 25-376 and the spreadsheet associated with document DA 25-376 listing the proceedings proposed for termination can also be downloaded in Word or Portable Document Format (PDF) at: https://www.fcc.gov/document/fcc-looks-clear-backlog-inactive-proceedings-0.

To request this document in accessible formats for people with disabilities ( e.g., Braille, large print, electronic files, audio format) or to request reasonable accommodations ( e.g., accessible format documents, sign language interpreters, CART), send an email to fcc504@fcc.gov or call the FCC's Consumer and Governmental Affairs Bureau at (202) 418-0530.

Purpose: The Advisory Committee on Immunization Practices is charged with advising the Director, Centers for Disease Control and Prevention (CDC), on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under applicable provisions of the Affordable Care Act and section 2713 of the Public Health Service Act, immunization recommendations of ACIP that have been adopted by the Director, CDC, and appear on CDC immunization schedules generally must be covered by applicable health plans.

Matters To Be Considered: The agenda will include discussions on anthrax vaccines, chikungunya vaccines, COVID-19 vaccines, cytomegalovirus (CMV) vaccine, Human papillomavirus (HPV) vaccine, influenza vaccines, Lyme disease vaccine, meningococcal vaccines, pneumococcal vaccines, Respiratory Syncytial Virus (RSV) vaccines for adults, and RSV vaccines for maternal and pediatric populations. Recommendation votes are scheduled for COVID-19 vaccines, HPV vaccine, influenza vaccines, meningococcal vaccine, RSV vaccines for adults, and RSV vaccine for maternal and pediatric populations. Vaccines for Children (VFC) votes are scheduled for COVID-19 vaccines, HPV vaccine, influenza vaccines, and RSV vaccines. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda, visit https://www.cdc.gov/acip/meetings/index.html.

Meeting Information: The meeting will be webcast live via the World Wide Web. For more information on ACIP, please visit the ACIP website: https://www.cdc.gov/acip.

Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/near-duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket.

Written Public Comment: The docket will be opened to receive written comments June 9-20, 2025. Written comments must be received by June 20, 2025.

Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes, including all votes relevant to the ACIP's Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below.

Procedure for Oral Public Comment: All persons interested in making an oral public comment at the June 25-27, 2025, ACIP meeting must submit a request at https://www.cdc.gov/acip/meetings/index.html between June 9-20, 2025, and no later than 11:59 p.m., EDT, June 20, 2025, according to the instructions provided.

If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a random draw to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by June 23, 2025. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to three minutes, and each speaker may speak only once per meeting.

The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

The Secretary of the U.S. Department of Health and Human Services (HHS) and the Secretary of the U.S. Department of Transportation established the Air Ambulance and Patient Safety (AAQPS) Advisory Committee on August 22, 2023, in response to Section 106 of the No Surprises Act, enacted as part of the Consolidated Appropriations Act, 2021, div. BB, tit. I, Public Law 116-260 (December 27, 2020). The AAQPS Advisory Committee is tasked with reviewing options to establish quality, patient safety, and clinical capability standards for each clinical capability level of air ambulances. The AAQPS Advisory Committee held its first meeting on December 12, 2024.

The AAQPS Advisory Committee is governed by the provisions of the Federal Advisory Committee Act, Public Law 92-463 (October 6, 1972), as amended Title 5 of the United States Code (5 U.S.C. Ch.10).

The AAQPS Advisory Committee will review options to establish quality, patient safety, and clinical capability standards for each clinical capability level of air ambulances at the July 10, 2025, meeting. The Centers for Medicare & Medicaid Services (CMS) will make available a more detailed agenda and meeting materials no later than 3 days before the meeting on the AAQPS Committee website at https://www.cms.gov/medicare/regulations-guidance/advisory-committees/advisory-committee-air-ambulance-quality-and-patient-safety.

The meeting is open to the public for virtual attendance on a first-come, first-served basis, as there may be capacity or technical limitations. Please see the ADDRESSES section to view the meeting link.

We are committed to providing equal access to this meeting for all participants. If you need alternative formats or services because of a disability, such as a sign language interpreter, please contact the person listed in the FOR FURTHER INFORMATION CONTACT section no later than 2 weeks before the meeting.

CMS will accept oral comments, which must be limited to the objectives of the Committee and limited to 3 minutes per person. Individual members of the public who wish to present oral comments must register and provide a written copy of prepared remarks for inclusion in the meeting records and for circulation to AAQPS Advisory Committee members. All prepared remarks submitted on time will be considered as part of the meeting's record.

Members of the public may submit written comments for consideration by the Committee at any time via email to AAQPS@cms.hhs.gov. Additionally, members of the public will have the opportunity to submit comments during the July 10, 2025, virtual meeting through the chat feature of the Zoom webinar platform. Members of the public are encouraged to email lengthy written comments to AAQPS@cms.hhs.gov. Advance submissions that are within the scope of the Advisory Committee will become part of the official record of the meeting.

The Administrator of the Centers for Medicare & Medicaid Services (CMS), Mehmet Oz, having reviewed and approved this document, authorizes Vanessa Garcia, who is the Federal Register Liaison, to electronically sign this document for purposes of publication in the Federal Register .

In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

This information collection helps support implementation of the Medical Device User Fee and Modernization Act of 2002 (MDUFMA) (Pub. L. 107-250), most recently reauthorized in 2022 from October 1, 2022, until September 30, 2027. To qualify as a “small business,” and therefore be eligible for reduced or waived fees, respondents submit information to FDA so we can determine whether the applicant is a small business. Sections 738(d)(2)(A) and (e)(2)(A) of the FD&C Act (21 U.S.C. 379j(d)(2)(A) and (e)(2)(A)) define a “small business” as an entity that reported $100 million or less of gross receipts or sales in its most recent Federal income tax return, including such returns of its affiliates, partners, and parent firms. If a firm's gross receipts or sales are no more than $30 million (including all affiliates, partners, and parent firms), they will also qualify for a waiver of the fee for their first (ever) premarket application (PMA), product development protocol (PDP), biological licensing application (BLA), or premarket report.

In the Federal Register of February 22, 2024 (89 FR 13349), FDA announced the availability of the draft guidance for industry entitled “Select Updates for the Medical Device User Fee Small Business Qualification and Certification Guidance” (available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/select-updates-medical-device-user-fee-small-business-qualification-and-certification-guidance ). The guidance includes select updates to the guidance “Medical Device User Fee Small Business Qualification and Certification” (August 2018), available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/medical-device-user-fee-small-business-qualification-and-certification ) which describe how FDA plans to determine if a small business is experiencing “financial hardship” that makes them eligible for a waiver of their registration fee. A manufacturer seeking the small business fee waiver may provide evidence of a reported $1 million or less of gross receipts or sales in its most recent Federal income tax return, as well as evidence that they have filed a petition for bankruptcy and that the bankruptcy is currently active. The proposed updates also reflect that firms based in jurisdictions without a National Taxing Authority (NTA) need not submit a certification from their NTA to be eligible for fee waivers or reductions.

Additionally, FDA intends to consolidate the forms previously known as FDA 3602 and FDA 3602A into a single webform, the “MDUFA Small Business Request” (MDUFA SBR, FDA 3602N) to be completed by foreign as well as U.S. businesses/applicants via FDA's Center for Devices and Radiological Health Customer Collaboration Portal (CDRH Portal). We have also added to the MDUFA SBR a “Registration & Listing Waiver” section which asks if the business/applicant will apply for a registration and listing fee waiver and whether they have applied in the past. Applicants seeking this waiver will be asked to include proof of bankruptcy documentation in the supporting documentation section.

In the Federal Register of February 22, 2024 (89 FR 13349), FDA published a 60-day notice requesting public comment on the proposed collection of information. Three comments were received, but they were not related to the information collection.

FDA estimates the burden of this collection of information as follows:

As discussed previously in this document, we have proposed updates to the guidance document, “Medical Device User Fee Small Business Qualification and Certification Guidance for Industry, Food and Drug Administration Staff and Foreign Governments,” (August 2018) consistent with amendments to section 738(a)(3)(B) of the FD&C Act. Because we assume that current bankruptcy documentation is readily available to applicants, we assume no change to the Average Burden per Response for this information collection.

Aside from the changes already discussed, the total burden estimate remains unchanged from the last OMB approval.

Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency's functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

Title of the Collection: HHS 42 CFR subpart B; Sterilization of Persons in Federally Assisted Family Planning Projects.

Type of Collection: Renewal.

OMB No. 0937-0166.

Abstract: The Department of Health and Human Service, Office of Population Affairs is requesting an extension of a currently approved collection for the disclosure and recordkeeping requirements codified at 42 CFR part 50, subpart B (“Sterilization of Persons in Federally Assisted Family Planning Projects”). The consent form solicits information to assure voluntary and informed consent to persons undergoing sterilization in programs of health services which are supported by federal financial assistance administered by the United States Public Health Service (PHS). It provides additional procedural protection to the individual and the regulation requires that the consent form be a copy of the form that is appended to the PHS regulation. In 2003, the PHS sterilization consent form was revised to conform to OMB government-wide standards for the collection of race/ethnicity data and to incorporate the PRA burden statement as part of the consent form. We are requesting a three-year extension.

Notice of these meetings is provided in accordance with the Federal Advisory Committee Act. 5 U.S.C. 1009(a)(2) through implementing regulations at 41 CFR 102-3.150. The MHCC was established by the National Manufactured Housing Construction and Safety Standards Act of 1974, 42 U.S.C. 5403(a)(3), as amended by the Manufactured Housing Improvement Act of 2000 (Pub. L. 106-569). According to 42 U.S.C. 5403, as amended, the purposes of the MHCC are to:

(1) Provide periodic recommendations to the Secretary to adopt, revise, and interpret the Federal manufactured housing construction and safety standards in accordance with this subsection;

(2) Provide periodic recommendations to the Secretary to adopt, revise, and interpret the procedural and enforcement regulations, including regulations specifying the permissible scope and conduct of monitoring in accordance with subsection (b); and

(3) Be organized and carry out its business in a manner that guarantees a fair opportunity for the expression and consideration of various positions and for public participation.

The MHCC is deemed an advisory committee not composed of Federal employees.

Interested parties wishing to make comments on the business of the MHCC are encouraged to register by or before Friday, June 20, 2025, by contacting HUD's Administering Organization for the MHCC (AO), Home Innovation Research Labs; Attention: Kevin Kauffman, 400 Prince Georges Blvd., Upper Marlboro, MD 20774, or email to mhcc@homeinnovation.com or call 1-888-602-4663. Written comments are encouraged. The MHCC strives to accommodate citizen comments to the extent possible within the time constraints of the meeting agenda. Advance registration is strongly encouraged. The MHCC will provide an opportunity for public comments on specific matters before the MHCC.

The Department of Housing and Urban Development (HUD), Office of Manufactured Housing Programs, is providing an opportunity for the MHCC to discuss appropriate standards and requirements for multi-story manufactured homes that would not have upper floors built on a permanent chassis. HUD is proposing to modify the standards related to manufactured home chassis requirements within the Manufactured Housing Construction and Safety Standards. HUD is scheduling this meeting with the MHCC to allow robust discussion, analysis, and consideration as the committee is responsible to provide recommendations to the Secretary for the purposes of proceeding with changes to the standards. This meeting is scheduled for one day to provide sufficient time for thorough consideration. HUD, therefore, strongly encourages active participation by committee members, stakeholders, and other interested parties.

The purposes of the Endangered Species Act of 1973, as amended (hereafter referred to as ESA; 16 U.S.C. 1531 et seq. ), are to provide a means to conserve the ecosystems upon which endangered and threatened species depend (listed species), to develop a program for the conservation of listed species, and to achieve the purposes of certain treaties and conventions. Moreover, the ESA states that it is the policy of Congress that the Federal government will seek to conserve endangered and threatened species and use its authorities to further the statutory purposes (16 U.S.C. 1531(c)(1)). The ESA's implementing regulations are in title 50 of the Code of Federal Regulations (CFR).

Section 10(a)(1)(A) of the ESA authorizes the issuance of permits, under certain terms and conditions, for any act otherwise prohibited by section 9 for scientific purposes or to enhance the propagation or survival of the affected species. In 1999, we promulgated regulations (at 50 CFR 17.22(c) and (d) and 50 CFR 17.32(c) and (d)) and finalized policies regarding safe harbor agreements and candidate conservation agreements with assurances to incentivize the use of enhancement of survival permits to further species recovery and conservation (64 FR 32706, 32717, and 32726; June 17, 1999). We updated our implementing regulations for section 10(a) on April 12, 2024 (89 FR 26070; 2024 rule) to simplify the requirements for enhancement of survival permits by combining safe harbor agreements and candidate conservation agreements with assurances into one agreement type called a conservation benefit agreement. The 2024 rule also clarified which statutory provision the U.S. Fish and Wildlife Service (Service) authorizes the proposed take, either through an enhancement of survival permit (section 10(a)(1)(A)) or an incidental take permit (section 10(a)(1)(B)). Additional regulatory changes were made to reduce costs and times associated with negotiating and developing the required documents to support applications.

The purpose of Section 10(a)(1)(A) conservation benefit agreements is to incentivize voluntary conservation of listed and at-risk species on non-Federal lands. The enhancement of survival permits associated with conservation benefit agreements are intended to incentivize voluntary conservation by authorizing the take of covered species that may result from implementing the approved conservation benefit agreement. These permits also provide assurances that the Service will not in the future require an increased commitment or impose additional restrictions on the permittee's current management and use of land, water, or financial resources. As a result, a property owner may continue ongoing activities and implement beneficial conservation measures without concern that their activities may be curtailed by increasing populations or distribution of a listed species or a species that may become listed in the future. Therefore, property owners managing or improving habitat that could be used by a species that is listed or could be listed in the future, or establishing new populations of such species, have an incentive to continue their activities without fear of being subjected to increased regulatory burdens in the future. In general, take associated with working lands ( e.g., agriculture and silviculture) that are managed in a sustainable fashion to improve conditions for listed and at-risk species, may be appropriate under this authority depending upon the proposed covered activities.

The purpose of Section 10(a)(1)(B) is to provide a means for non-federal entities to ensure ESA compliance when otherwise lawful activities may result in incidental take of listed species or a species that may become listed in the future. Section 10(a)(1)(B) of the ESA authorizes the issuance of permits, under certain terms and conditions, to authorize take that would be otherwise prohibited by section 9, provided the taking is incidental to, and not the purpose of, carrying out an otherwise lawful activity. Under section 10(a)(1)(B), the impacts of the take associated with the otherwise lawful activities must be minimized and mitigated to the maximum extent practicable, i.e., the nature of the associated habitat conservation plan is a mitigation plan to minimize and offset the adverse impacts to the species that are incidental to otherwise lawful activities. Ultimately, issuance of an incidental take permit under section 10(a)(1)(B) is beneficial because they strike a balance for non-Federal entities to continue projects of their choosing on their lands while also providing for species protection.

The Service invites information and comments from anyone who would like to submit information and/or suggestions for improving the efficiency and effectiveness of conservation benefit agreements, habitat conservation plans, and their respective enhancement of survival permits and incidental take permits. We invite all private and public stakeholders, Tribes or Tribal governments, as well as the general public to comment or provide any information that they believe should be taken into consideration. We particularly seek comments concerning:

(1) Barriers that prevent applicants from pursuing development of conservation benefit agreements and habitat conservation plans;

(2) Methods to streamline conservation benefit agreement and habitat conservation plan development and their associated permit issuance;

(3) Strategies to enhance Service communications on conservation benefit agreements, habitat conservation plans, and their associated permits;

(4) Whether any clarification is needed on the roles and responsibilities of the Service and applicants during conservation benefit agreement and habitat conservation plan development and permit issuance;

(5) Funding and resources necessary to develop and implement conservation benefit agreements and habitat conservation plans;

(6) Strategies the Service could pilot to improve the overall effectiveness of the section 10(a) program.

In accordance with the Paperwork Reduction Act of 1995 and 5 CFR 1320.8(d)(1), we provide the general public, and other Federal agencies, with an opportunity to comment on new, proposed, revised, and continuing collections of information. This helps us assess the impact of our information collection requirements and minimize the public's reporting burden. It also helps the public understand our information collection requirements and provide the requested data in the desired format.

As part of our continuing effort to reduce paperwork and respondent burdens, we invite the public and other Federal agencies to comment on new, proposed, revised, and continuing collections of information. We are especially interested in public comment addressing the following:

(1) Whether or not the collection of information is necessary for the proper performance of the functions of the agency, including whether or not the information will have practical utility;

(2) The accuracy of our estimate of the burden for this collection of information, including the validity of the methodology and assumptions used;

(3) Ways to enhance the quality, utility, and clarity of the information to be collected; and

(4) How might the agency minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of response.

Comments that you submit in response to this notice are a matter of public record. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so.

Abstract: The BIA is seeking renewal of the approval for the information collection conducted under 25 CFR 23.13, implementing the Indian Child Welfare Act (25 U.S.C. 1901). The information collection allows BIA to receive written requests by State courts that appoint counsel for an indigent Indian parent or Indian custodian in an involuntary Indian child custody proceeding when appointment of counsel is not authorized by State law. The applicable BIA Regional Director uses this information to decide whether to certify that the client in the notice is eligible to have his/her counsel compensated by the BIA in accordance with the Indian Child Welfare Act.

Title of Collection: Payment for Appointed Counsel in Involuntary Indian Child Custody Proceedings in State Courts, 25 CFR 23.13.

OMB Control Number: 1076-0111.

Form Number: None.

Type of Review: Extension of a currently approved collection.

Respondents/Affected Public: State courts.

Total Estimated Number of Annual Respondents: 2.

Total Estimated Number of Annual Responses: 2.

Estimated Completion Time per Response: 3 hours.

Total Estimated Number of Annual Burden Hours: 6 hours.

Respondent's Obligation: Required to obtain a benefit.

Frequency of Collection: On occasion.

Total Estimated Annual Nonhour Burden Cost: $0.

An agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The authority for this action is the Paperwork Reduction Act of 1995 (44 U.S.C. 3501).

In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. 3501) and 5 CFR 1320.8(d)(1), we provide the general public, and other Federal agencies, with an opportunity to comment on new, proposed, revised, and continuing collections of information. This helps us assess the impact of our information collection requirements and minimize the public's reporting burden. It also helps the public understand our information collection requirements and provide the requested data in the desired format.

As part of our continuing effort to reduce paperwork and respondent burdens, we invite the public and other Federal agencies to comment on new, proposed, revised, and continuing collections of information. We are especially interested in public comment addressing the following:

(1) Whether or not the collection of information is necessary for the proper performance of the functions of the agency, including whether or not the information will have practical utility;

(2) The accuracy of our estimate of the burden for this collection of information, including the validity of the methodology and assumptions used;

(3) Ways to enhance the quality, utility, and clarity of the information to be collected; and

(4) How might the agency minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of response.

Comments that you submit in response to this notice are a matter of public record. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so.

Abstract: Enrollment data is an important source of information which allows the Indian Affairs and other Federal agencies to equitably distribute resources because it is a quantifiable representation of a Tribe's population. Different population sizes generally require different levels of services and resources. BIA must collect this information to ensure effective, accurate, and timely distribution of assistance to respond to funds specifically appropriated for Indian Country, where applicable. The authority for this information collection is 25 U.S.C. 2.

Title of Collection: Tribal Enrollment Count.

OMB Control Number: 1076-0197.

Form Number: None.

Type of Review: Extension of a currently approved collection.

Respondents/Affected Public: Federally recognized Tribes.

Total Estimated Number of Annual Respondents: 574 per year.

Total Estimated Number of Annual Responses: 574 per year.

Estimated Completion Time per Response: 1 hour.

Total Estimated Number of Annual Burden Hours: 574 hours.

Respondent's Obligation: Voluntary.

Frequency of Collection: Annually.

Total Estimated Annual Nonhour Burden Cost: $0.

An agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The authority for this action is the Paperwork Reduction Act of 1995 (44 U.S.C. 3501).

In accordance with the Paperwork Reduction Act of 1995 and 5 CFR 1320.8(d)(1), we provide the general public, and other Federal agencies, with an opportunity to comment on new, proposed, revised, and continuing collections of information. This helps us assess the impact of our information collection requirements and minimize the public's reporting burden. It also helps the public understand our information collection requirements and provide the requested data in the desired format.

As part of our continuing effort to reduce paperwork and respondent burdens, we invite the public and other Federal agencies to comment on new, proposed, revised, and continuing collections of information. We are especially interested in public comment addressing the following:

(1) Whether or not the collection of information is necessary for the proper performance of the functions of the agency, including whether or not the information will have practical utility;

(2) The accuracy of our estimate of the burden for this collection of information, including the validity of the methodology and assumptions used;

(3) Ways to enhance the quality, utility, and clarity of the information to be collected; and

(4) How might the agency minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of response.

Comments that you submit in response to this notice are a matter of public record. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so.

Abstract: Enhancing the public health and safety capacity throughout Indian Affairs is a force multiplier in achieving the goals of our agency and in meeting the Occupational Safety and Health Act of 1970 (29 U.S.C. 654) directive to create a place of employment free from recognized hazards. The purpose of this survey is to identify and prioritize public health issues and needs and enhance the public health and safety capacity throughout Indian country. The Office of Facilities, Property and Safety Management (OFPSM) Public Health and Safety (PHS) Team will use survey results to develop and coordinate action plans.

Title of Collection: Indian Affairs Public Health Needs Assessment.

OMB Control Number: 1076-0200.

Form Number: None.

Type of Review: Extension of a currently approved collection.

Respondents/Affected Public: Tribal governments, bureau-operated and tribally-controlled schools and justice programs.

Total Estimated Number of Annual Respondents: 1,000.

Total Estimated Number of Annual Responses: 1,000.

Estimated Completion Time per Response: 10 minutes.

Total Estimated Number of Annual Burden Hours: 167.

Respondent's Obligation: Voluntary.

Frequency of Collection: On occasion.

Total Estimated Annual Nonhour Burden Cost: $0.

An agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The authority for this action is the Paperwork Reduction Act of 1995 (44 U.S.C. 3501).

In 1992, the Montana Department of Environmental Quality (MDEQ) issued a mining permit pursuant to the Montana equivalent of the Surface Mining Control and Reclamation Act of 1977 (SMCRA) for the Bull Mountains Mine. Over time, ownership changed, and in 2008, SPE applied to lease the Federal coal from the Bureau of Land Management (BLM) under the Mineral Leasing Act of 1920. The BLM prepared an EA and issued a finding of no significant impact (FONSI) in 2011 on the decision to approve the lease. Montana has approved several amendments to SPE's State surface mining permit, and most of the area covered by Federal coal lease MTM-97988 is within what is known as Amendment (AM) 3. OSMRE first recommended, and the Assistant Secretary of Land and Minerals Management (ASLM) first approved, a modification to the Bull Mountains Mine's operation and reclamation ( i.e., mining plan modification) in 2015. After legal challenge, ASLM approved another mining plan modification for the same lease in 2018. Additional legal challenges led to the judicial vacatur of the 2018 mining plan modification in 2023. SPE is now seeking a new mining plan modification to allow it to continue mining leased Federal coal. Without a new approved mining plan modification from the ASLM to mine the leased Federal coal, SPE would be unable to access most of the remaining non-Federal coal resources within AM 3 due to the checkerboard mineral ownership pattern.

This FEIS was prepared in response to the Ninth Circuit's opinion that OSMRE violated NEPA when it failed to provide a convincing statement of reasons in its 2018 EA and FONSI about why greenhouse gas emissions from the mine were not significant, and the district court's subsequent vacatur of the 2018 mining plan approval for AM 3. Before SPE can continue to mine the leased Federal coal within AM 3, it must obtain approval from the ASLM. To support the ASLM's decision, OSMRE must prepare a mining plan decision document, which includes environmental documents, such as those needed for compliance with NEPA, and a recommendation to ASLM to either approve, disapprove, or approve with conditions, the proposed mining plan modification. This NEPA analysis informs OSMRE's recommendation.

SPE's need for this action is to exercise its rights under Federal coal lease MTM-97988 granted by the BLM to access and mine the Federal coal reserves, in accordance with the mining and reclamation plan approved by MDEQ as AM 3 to the State surface mining permit. ASLM approval of the Federal mining plan modification is required to mine Federal coal reserves within the AM 3 mining area.

Under the Proposed Action, OSMRE would recommend to the ASLM to approve the mining plan modification as proposed by SPE. If approved by the ASLM, the Proposed Action would allow the recovery of approximately 22.8 million tons (Mt) of saleable Federal coal and approximately 34.5 Mt of adjacent saleable non-Federal coal over a period of up to 9 years.

The FEIS analyzes three alternatives:

• No Action, in which OSMRE would recommend that the ASLM disapprove the mining plan modification. If disapproved by the ASLM, SPE would be unable to mine approximately 22.8 Mt of saleable Federal coal and approximately 34.5 Mt of saleable non-Federal coal in AM 3. However, under this alternative, the mine would not be expected to immediately shut down and go into reclamation because, within an estimated 1-year period, SPE could recover approximately 10.0 Mt of remaining saleable coal in the permit area without accessing Federal coal.

• Proposed Action, in which OSMRE would recommend that the ASLM approve the mining plan modification. If approved by the ASLM, the Proposed Action would authorize SPE to continue coal mining on approximately 1,239.6 acres of Federal coal lands and approximately 1,840.7 acres of adjacent non-Federal coal lands in AM3; and allow for the recovery of approximately 22.8 Mt of saleable Federal coal and approximately 34.5 Mt of adjacent saleable non-Federal coal over a period of up to 9 years.

• Partial Mining Alternative, in which OSMRE would recommend that the ASLM approve the mining plan modification with a condition to limit the approval to approximately 5 years. If approved by the ASLM, the Partial Mining Alternative would sunset the mining plan modification approval for Federal coal within AM 3 after approximately 5 years, at which time no additional Federal coal would be mined unless SPE applied for, and obtained, a separate mining plan modification approval to mine the remaining Federal coal. During this 5-year approval term, approximately 1,005.2 acres of Federal coal lands and 1,709.1 acres of non-Federal coal lands would be disturbed, and approximately 18.7 Mt of Federal coal and 32.2 Mt of non-Federal coal would be recovered.

Based on the analyses contained in the FEIS, OSMRE has selected the Proposed Action as the preferred alternative.

Reasonably foreseeable effects of mining Federal coal have been evaluated for the following resources in the FEIS and ROD:

None at this time.

OSMRE issued a notice of intent (NOI) to prepare an environmental impact statement (EIS) in the Federal Register and announced the NOI through a news release and on its website and hosted two 30-day public scoping periods. OSMRE requested public scoping comments to identify any additional relevant issues concerning the mine expansion that should be evaluated in the EIS. The public was provided the opportunity to comment on the Project via mail, email, and during the public scoping meeting. OSMRE received a total of 311 comment submittals from Federal and State agencies, non-governmental organizations, and members of the public during the public scoping periods. Comment letters received during the public scoping periods have been reviewed and a description of issues analyzed are summarized in the FEIS. In addition, OSMRE had solicited public comment on previous NEPA documents related to this approval; those comments and the responses given at that time helped inform this FEIS.

OSMRE is the lead agency for this EIS. The BLM and EPA are cooperating agencies on the EIS.

Assistant Secretary for Land and Minerals Management.

On January 20, 2025, President Donald J. Trump issued Executive Order (E.O.) 14156—“Declaring a National Energy Emergency,” which declared a national energy emergency and directed Federal agencies to expedite permits and approvals for energy projects, including those on Federal lands, using emergency provisions. During an emergency, a responsible official of the Department can adopt alternative arrangements to comply with NEPA before taking “urgently needed actions.” (43 CFR 46.150). On April 23, 2025, CEQ authorized the use of alternative arrangements for projects that respond to the national energy emergency and the Department subsequently adopted alternative arrangements for qualifying projects to comply with NEPA.

After reviewing SPE's request that the Department apply its alternative arrangements to its proposed mining plan modification, the ASLM approved the alternative arrangement for NEPA compliance for this energy-related project on May 12, 2025. In reaching this determination, the ASLM relied on SPE's request for alternative arrangement, E.O. 14156, E.O. 14154 (“Unleashing American Energy”), E.O. 14261 (“Reinvigorating America's Beautiful Clean Coal Industry”), Secretary's Order (S.O.) 3417, S.O. 3418, various documents related to the ongoing NEPA analysis for this proposed mining plan modification, and consultations with OSMRE. Importantly, the ASLM concluded that this proposed project seeks to advance energy production and would export nearly all its coal to Japan and South Korea, important defense allies of the United States. Finally, the ASLM also determined that additional public comment was unnecessary due to the prior robust opportunities for public participation and the fact that another 10-day comment period on another NOI was unlikely to yield substantive comments.

Informed by, at a minimum, the material required at 30 CFR 746.13, including information prepared in compliance with NEPA, OSMRE must make a recommendation to the ASLM about the proposed Federal mining plan modification associated with AM 3. The ASLM will use OSMRE's recommendation to decide whether a new mining plan modification is approved, disapproved, or approved with conditions.

As documented in the ROD, OSMRE is recommending that the ASLM approve the proposed mining plan modification, including the entire area covered by AM 3, as discussed in the EIS.

On May 30, 2024, Electrolux Consumer Products, Inc., Charlotte, North Carolina, filed a petition with the U.S. International Trade Commission (“Commission”) and the U.S. Department of Commerce (“Commerce”) alleging that an industry in the United States is materially injured or threatened with material injury by reason of less than-fair-value (“LTFV”) imports of large top mount combination refrigerator-freezers from Thailand. 1 Effective May 30, 2024, the Commission instituted antidumping duty investigation No. 731-TA-1696 (Preliminary). 2 On July 26, 2024, the Commission published its preliminary affirmative injury determination and commenced the final phase of its LTFV investigation. 3 On January 29, 2025, Commerce published its preliminary determination of sales at LTFV, pursuant to Section 733(b) of the Tariff Act of 1930 (“Act”). 4 On May 28, 2025, counsel for petitioner filed with the Commission and Commerce a request to withdraw its antidumping petition regarding imports of large top-mount combination refrigerator-freezers from Thailand. 5

Authority: Section 207.40(a) of the Commission's Rules of Practice and Procedure stipulates that the Commission may terminate an investigation upon withdrawal of the petition by the petitioner, provided that Commerce has made a determination pursuant to section 702(c), 703(b), 732(c) or 733(b) of the Act. Accordingly, we are terminating this investigation pursuant to section 207.40(a) of the Commission's rules (19 CFR 207.40(a)). This notice is published pursuant to section 201.10 of the Commission's rules (19 CFR 201.10).

The Commission instituted this investigation on February 26, 2025, based on a complaint filed on behalf of Razor USA LLC of Cerritos, California and Shane Chen of Camas, Washington (collectively, “Complainants”). 90 FR 10,730 (Feb. 26, 2025). The complaint, as amended, alleges violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain motorized self-balancing vehicles by reason of the infringement of certain claims of U.S. Patent No. RE46,964; U.S. Patent No. RE49,608; and U.S. Patent No. D739,906. Id. The complaint further alleges that an industry in the United States exists or is in the process of being established as required by the applicable Federal Statute. Id. The Commission's notice of investigation named five respondents: Golabs Inc. d/b/a Gotrax of Carrollton, Texas; Dongguan Saibotan Nengyuan Keji Co., Ltd. d/b/a “Gyroor US” of Guangdong, China; Gyroor Technology (CHINA) Co., Ltd. d/b/a Gyroor of Guangdong, China; Shenzhen Chitado Technology Co., Ltd. d/b/a Gyroor of Guangdong, China; and Unicorn Network, LLC. d/b/a Sisigad (“Sisigad”) of Dover, Delaware. Id.

Respondent Sisigad has been found in default. Order No. 7 (Apr. 16, 2025), unreviewed by Comm'n Notice (May 5, 2025).

On April 30, 2025, Complainants filed an unopposed motion to amend the complaint and NOI by adding a new respondent, Tao Motor, of Lishui City, China. The motion argued that good cause exists to add Tao Motor as a respondent and there is no prejudice to any party or the public interest by adding Tao Motor to the investigation.

On May 13, 2025, the ALJ issued the subject ID (Order No. 10), finding good cause to grant Complainants' unopposed motion to amend the complaint and NOI by adding Tao Motor. The ALJ found there is good cause to add Tao Motor as a respondent to this investigation and that the amendments will not prejudice any of the parties or the public interest. Order No. 10 at 2. No petitions for review were filed.

The Commission has determined not to review the subject ID. Accordingly, Tao Motor is hereby added as a respondent to this investigation.

The Commission vote for this determination took place on June 3, 2025.

The authority for the Commission's determination is contained in section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, and in Part 210 of the Commission's Rules of Practice and Procedure, 19 CFR part 210.

The Commission instituted this investigation on April 6, 2023, based on a complaint filed by Serendia, LLC of Lake Forest, California (“Serendia”). 88 FR 20551-52 (Apr. 6, 2023). The complaint, as supplemented, alleges violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain dermatological treatment devices and components thereof by reason of infringement of claims 1, 2, 5, 6, 9-14, 16, 17, 19, and 22 of the '836 patent; claims 1-5, 7-10, and 15 of U.S. Patent No. 10,058,379; claims 1-10 of the '444 patent; claims 1, 2, 4, 5, 8, 9, 11-13, 16, and 17 of the '536 patent; claims 1 and 6-15 of the '774 patent; and claims 1, 5-7, 9, 10, and 12-19 of the '812 patent. Id. at 20551. The complaint further alleges that a domestic industry exists. Id. The Commission's notice of investigation named as respondents Sung Hwan E&B Co., LTD. d/b/a SHEnB Co. LTD of Seoul, Republic of Korea; Aesthetics Biomedical, Inc. of Phoenix, Arizona; Cartessa Aesthetics, LLC of Melville, New York; Lutronic Corporation of Goyang-si, Republic of Korea; Lutronic Aesthetics, Inc., also known as Lutronic, Inc. of Billerica, Massachusetts; Lutronic, LLC of Billerica, Massachusetts; Ilooda, Co., Ltd. of Anyang-si, Republic of Korea; Cutera, Inc. of Brisbane, California; Rohrer Aesthetics, LLC of Homewood, Alabama; Rohrer Aesthetics, Inc. of Homewood, Alabama; Jeisys Medical Inc. of Seoul, Republic of Korea (“Jeisys”); Cynosure, LLC of Westford, Massachusetts (“Cynosure”); and EndyMed. Id. at 20552. The Office of Unfair Import Investigations (“OUII”) is also participating in the investigation. Id.

The Commission subsequently terminated the investigation as to all asserted patent claims except for claims 1, 9, and 22 of the '836 patent; claims 11 and 16 of the '536 patent; claim 14 of the '774 patent; claims 5, 13, and 18 of the '812 patent; and claims 4, 6, and 7 of the '444 patent. See Order No. 16 (June 29, 2023), unreviewed by Comm'n Notice (July 20, 2023); Order No. 27 (Sept. 25, 2023), unreviewed by Comm'n Notice (Oct. 16, 2023); Order No. 43 (Nov. 8, 2023), unreviewed by Comm'n Notice (Dec. 12, 2023).

The Commission also subsequently terminated the investigation as to all respondents except for EndyMed. See Order No. 26 (Sept. 18, 2023), unreviewed by Comm'n Notice (Oct. 16, 2023); Order No. 38 (Oct. 27, 2023), unreviewed by Comm'n Notice (Nov. 20, 2023); Order No. 45 (Nov. 15, 2023), unreviewed by Comm'n Notice (Dec. 15, 2023); Order No. 47 (Nov. 20, 2023), unreviewed by Comm'n Notice (Dec. 15, 2023); Order No. 53 (Apr. 11, 2024), unreviewed by Comm'n Notice (May 8, 2024); Order No. 51 (Dec. 13, 2023), unreviewed by Comm'n Notice (Jan. 10, 2024); Order No. 64 (Dec.18, 2024), unreviewed by Comm'n Notice (Jan. 17, 2025).

The ALJ held a Markman hearing on July 13, 2023, and issued a Markman Order on October 25, 2023, construing certain disputed claim terms. Order No. 35 (Oct. 25, 2023). The ALJ found the pending claims of the '444 patent, claims 4, 6, and 7, indefinite in the Markman Order and did not consider those claims any further in the Investigation. Markman (Order No. 35) at 62.

The ALJ held an evidentiary hearing on November 1-2, 6-7, 2023 and December 11-12, 2023, and received post-hearing briefs thereafter. Remaining in the investigation at that time were respondents EndyMed, Jeisys, and Cynosure and claims 1, 9, and 22 of the '836 patent; claims 11 and 16 of the '536 patent; claim 14 of the '774 patent; and claims 5, 13, and 18 of the '812 patent.

On December 19, 2024, the ALJ issued the final initial determination (“ID”) in this investigation finding a violation of section 337 as to claims 1, 9, and 22 of the '836 patent; claims 11 and 16 of the '536 patent; claim 14 of the '774 patent; and claims 5, 13, and 18 of the '812 patent by respondents EndyMed, Jeisys, and Cynosure. The ID found that by appearing and participating in the investigation, the parties consented to personal jurisdiction at the Commission. ID at 13. The ID found the importation requirement under 19 U.S.C. 1337(a)(1)(B) satisfied and that the Commission has in rem jurisdiction, noting that “[t]he Private Parties entered stipulations with respect to the importation of Accused Products wherein each Respondent stipulated that they have imported to the United States, sold for importation into the United States, and/or sold within the United States after importation at least one Accused Product.” Id. The ID found that Serendia has the exclusive rights and ownership in the Asserted Patents and thus has “standing” to assert the patents in this investigation. Id. at 23. The ID further found that Serendia successfully proved that the accused products directly infringe the Asserted Claims. ID at 70-88, 173-184, 216-225. The ID further found that EndyMed also indirectly infringes the asserted claims of the '836 and '536 patents via inducement and contributory infringement. ID at 97-104, 185-188. The ID found that EndyMed failed to show that the Asserted Claims are invalid for obviousness (ID at 120-145, 209-216, 230-232, 257-267). The ID found that EndyMed also failed to show that the asserted claims of the '536 patent are invalid for anticipation (ID at 196-209) and also failed to prove that the asserted claims of the '836 patent are invalid for lack of enablement (ID at 146-161), lack of written description support (ID at 161-167), or recite unpatentable subject matter under section 101 (ID at 167-173). The ID found the existence of a domestic industry that practices the Asserted Patents as required by 19 U.S.C. 1337(a)(2). ID at 104-110, 189-196, 226-230, 247-256, 267-300. Accordingly, the ID found a violation of section 337 as to four of the remaining five patents.

The ID included the ALJ's recommended determination on remedy and bonding (“RD”). The RD recommended, should the Commission find a violation, issuance of a limited exclusion order and cease and desist orders against EndyMed. ID/RD at 302-111. Regarding the amount of bond to be imposed during the period of Presidential review, the ID recommended that “the Commission enter a bond in the amount of 85% of the price of value EndyMed Pure product and 70% of the value of the EndyMed Pro product during the PRP [period of Presidential review].” Id. at 314.

Regarding Jeisys and Cynosure, the ID noted that they have been terminated from the investigation by the ALJ, but that given the timing of the termination, the analyses pertaining to them contained in the ID would not be deleted. ID at ii n.1. The ID stated that once the Commission addresses the ID terminating them, “Jeisys and Cynosure are no longer parties in this Investigation,” and their “accused products will no longer be at issue in this Investigation and will not be subject to any determinations set forth in the ID.” Id.; Order No. 64 (Dec. 18, 2024) (terminating Jeisys and Cynosure from the investigation), unreviewed by Comm'n Notice (Jan. 17, 2025).

On January 2, 2025, Jeisys and Cynosure filed a petition for review, asking the Commission to set aside the findings in the ID pertaining to them because of their termination from the investigation.

January 10, 2025, Serendia and EndyMed filed respective petitions for review of the ID. On January 21, 2025, the parties, including OUII, filed responses to the petitions.

On February 28, 2025, the Commission determined to review the final ID in part. 90 FR 11433-36 (Mar. 6, 2023). Specifically, the Commission determined to review the final ID's findings on jurisdiction, standing, economic prong of domestic industry for all five patents, contributory infringement for the asserted claims of the '536, '774, '812, and '836 patents, secondary considerations for the '536 and '836 patents, and indefiniteness of the asserted claims of the '444 patent. The Commission requested briefing on certain issues under review and on remedy, the public interest, and bonding. Id.

In its notice of review, the Commission vacated the findings in the ID pertaining to Jeisys and Cynosure due to their termination from the investigation. 90 FR 11435 (Mar. 6, 2023).

On March 14, 2025, the parties filed initial submissions in response to the Commission's request for briefing. On March 21, 2025, the parties filed reply submissions.

Upon review of the parties' submissions, the ID, the RD, evidence of record, and the public interest, the Commission has determined that EndyMed violated section 337 by reason of importation and sale of articles that infringe asserted claims 1, 9, and 22 of the '836 patent; claims 11 and 16 of the '536 patent; claim 14 of the '774 patent; and claims 5, 13, and 18 of the '812 patent. Regarding the issues under review, the Commission has determined to (1) provide the modification in the accompanying Commission opinion for the ID's findings on jurisdiction and standing, (2) affirm the ID's findings on the economic prong of domestic industry for the reasons provided in the ID as supplemented in the opinion, (3) take no position on the ID's contributory infringement finding, (4) affirm the ID's findings on secondary considerations for the reasons provided in the ID, and (5) reverse and remand the ID's indefiniteness finding of the asserted claims of the '444 patent.

For the '444 patent, the Commission has determined to remand to the ALJ for further proceedings consistent with the Commission's opinion and remand order. The target date is extended to July 8, 2025. For remedy, the Commission has determined to issue a limited exclusion order prohibiting further importation of infringing products and cease and desist orders against EndyMed. The Commission has also determined that the public interest factors enumerated in paragraphs 337(d)(1) and (f)(1) (19 U.S.C. 1337(d)(1), (f)(1)) do not preclude the issuance of these remedial orders. The Commission has determined to set a bond in the amount of eighty-five percent (85%) of the entered value of the EndyMed Pure, and seventy percent (70%) of the entered value of the EndyMed Pro, for infringing products imported during the period of Presidential review pursuant to 19 U.S.C. 1337(j). The Commission's orders were delivered to the President and to the United States Trade Representative on the day of their issuance.

The Commission vote for this determination took place on June 3, 2025. The investigation is hereby terminated with respect to the '836, '536, '774, and '812 patents. The '444 patent is remanded to the ALJ.The authority for the Commission's determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR part 210).

Notice is hereby given that the Advisory Committee on Actuarial Examinations will meet by teleconference on Thursday, July 10, 2025, from 10:00 a.m. to 6:00 p.m. (ET), and Friday, July 11, 2025, from 10:00 a.m. to 4:00 p.m. (ET).

The purpose of the meeting is to discuss topics and questions that may be recommended for inclusion on future Joint Board examinations in actuarial mathematics and methodology referred to in 29 U.S.C. 1242(a)(1)(B) and to review the May 2025 Basic (EA-1) and Pension (EA-2L) Examinations in order to make recommendations relative thereto, including the minimum acceptable pass score. Topics for inclusion on the syllabus for the Joint Board's examination program for the November 2025 Pension (EA-2F) Examination also will be discussed.

A determination has been made as required by section 10(d) of the Federal Advisory Committee Act, 5 U.S.C. 1009(d), that the portions of the meeting dealing with the discussion of questions that may appear on the Joint Board's examinations and the review of the May 2025 Basic (EA-1) and Pension (EA-2L) Examinations fall within the exceptions to the open meeting requirement set forth in 5 U.S.C. 552b(c)(9)(B), and that the public interest requires that such portions be closed to public participation.

The portion of the meeting dealing with the discussion of the other topics will commence at 2:30 p.m. (ET) on July 10, 2025, and will continue for as long as necessary to complete the discussion, but not beyond 3:30 p.m. (ET). Time permitting, after the close of this discussion by Advisory Committee members, interested persons may make statements germane to this subject. Persons wishing to make oral statements should contact the Designated Federal Officer at NHQJBEA@IRS.GOV and include the written text or outline of comments they propose to make orally. Such comments will be limited to 10 minutes in length. Persons who wish to attend the public session should contact the Designated Federal Officer at NHQJBEA@IRS.GOV to obtain teleconference access instructions. Notifications of intent to make an oral statement or to attend the meeting must be sent electronically to the Designated Federal Officer by no later than July 3, 2025. In addition, any interested person may file a written statement for consideration by the Joint Board and the Advisory Committee by sending it to NQJBEA@IRS.GOV .

The Quarterly Census of Employment and Wages (QCEW) program is a Federal/State cooperative effort which compiles monthly employment data, quarterly wages data, and business identification information from employers subject to State Unemployment Insurance (UI) laws. These data are collected from State Quarterly Contribution Reports (QCRs) submitted to State Workforce Agencies (SWAs). The States send micro-level employment and wages data, supplemented with the names, addresses, and business identification information of these employers, to the BLS. The State data are used to create the BLS sampling frame, known as the longitudinal QCEW data. This file represents the best source of detailed industrial and geographical data on employers and is used as the sampling frame for most BLS surveys. The longitudinal QCEW data include the individual employers' employment and wages data along with associated business identification information that is maintained by each State to administer the UI program as well as the Unemployment Compensation for Federal Employees (UCFE) program.

The QCEW Report, produced for each calendar quarter, is a summary of these employer (micro-level) data by industry at the county level. Similar data for Federal Government employees covered by the UCFE program also are included in each State's report. These data are submitted by all 50 States, the District of Columbia, Puerto Rico, and the Virgin Islands to the BLS which then summarizes these micro-level data to produce totals for the States and the Nation. The QCEW Report provides a virtual census of nonagricultural employees and their wages, with approximately 56 percent of the workers in agriculture covered as well.

For employers having only a single physical location or worksite in the State and, thus, operating under a single industrial and geographical code, the data from the States' UI accounting files are sufficient for statistical purposes. However, such data are not sufficient for statistical purposes for those employers having multiple establishments or engaging in different industrial activities within the State. In such cases, the employer's QCR reflects only statewide employment and wages and is not disaggregated by establishment or worksite. Although data at these levels are sufficient for many purposes of the UI program, more detailed information is required to create a sampling frame and to meet the needs of several ongoing Federal/State statistical programs. The Multiple Worksite Report (MWR) is designed to supplement the QCR when more detailed information is needed.

Because of the data captured by the MWR, improved establishment business identification data elements have been incorporated into and maintained by the longitudinal QCEW database. The MWR collects a physical location address, secondary name (trade name, division, subsidiary, etc.), and reporting unit description (store number, plant name or number, etc.) for each worksite of multi-establishment employers.

Employers with more than one establishment reporting under the same UI account number within a State are requested to complete the MWR if the sum of the employment in all of their secondary establishments is 10 or greater. The primary worksite is defined as the establishment with the greatest number of employees. Upon receipt of the first MWR form, each employer is requested to supply business location identification information. Thereafter, this reported information appears on the MWR each quarter. The employer is requested to verify the accuracy of this business location identification information and to provide only the employment and wages for each worksite for that quarter. By using a standardized form, the reporting burden on many large employers, especially those engaged in multiple economic activities at various locations across numerous States, is reduced.

The function of the Report of Federal Employment and Wages (RFEW) is to collect employment and wages data for Federal establishments covered under the UCFE program. The MWR and RFEW are essentially the same. The MWR/RFEW forms are designed to collect data for each establishment of a multi-establishment employer.

No other standardized report is available to collect current establishment-level monthly employment and wages data by SWAs for statistical purposes each quarter from the private sector nor State and local governments. Also, no other standardized report currently is available to collect installation-level Federal monthly employment and wages data each quarter by SWAs for statistical purposes. Completion of the MWR is required by law in 31 States and territories.

Office of Management and Budget clearance is being sought for an extension of the Multiple Worksite Report and the Report of Federal Employment and Wages.

The BLS has taken steps to help reduce employer reporting burden by developing a standardized format for employers to use to send these data to the States in an electronic medium. The BLS established an Electronic Data Interchange (EDI) Collection Center to improve and expedite the MWR collection process. Employers who complete the MWR for multi-location businesses can submit employment and wages information on any electronic medium directly to the data collection center, rather than separately to each State agency. The data collection center then distributes the appropriate data to the respective States. In addition, the BLS developed a web-based system, MWRweb, to collect these data from small to medium-size businesses. The BLS continues to see much greater utilization of this reporting option.

The Bureau of Labor Statistics is particularly interested in comments that:

• Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility.

• Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used.

• Enhance the quality, utility, and clarity of the information to be collected.

• Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses.

Title of Collection: Multiple Worksite Report (MWR) and the Report of Federal Employment and Wages (RFEW).

OMB Number: 1220-0134.

Type of Review: Extension.

Affected Public: Business or other for-profits, Not-for-profit institutions, and the Federal Government.

Comments submitted in response to this notice will be summarized and/or included in the request for Office of Management and Budget approval of the information collection request; they also will become a matter of public record.

The Department of Labor, as part of the continuing effort to reduce paperwork and respondent ( i.e., employer) burden, conducts a preclearance consultation program to provide the public with an opportunity to comment on proposed and continuing information collection requirements in accordance with the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3506(c)(2)(A)). This program ensures that information is in the desired format, reporting burden (time and costs) is minimal, the collection instruments are clearly understood, and OSHA's estimate of the information collection burden is accurate. The Occupational Safety and Health Act of 1970 (OSH Act) (29 U.S.C. 651 et seq. ) authorizes information collection by employers as necessary or appropriate for enforcement of the OSH Act or for developing information regarding the causes and prevention of occupational injuries, illnesses, and accidents (29 U.S.C. 657). The OSH Act also requires that OSHA obtain such information with minimum burden upon employers, especially those operating small businesses, and to reduce to the maximum extent feasible unnecessary duplication of effort in obtaining information (29 U.S.C. 657).

The following sections describe who uses the information collected under each requirement, as well as how they use it. The collections of information specified in the Noise Standard (29 CFR 1910.95) protect workers from suffering material hearing impairment. The collections of information contained in the Noise Standard include conducting noise monitoring; notifying workers when they are exposed at or above an 8-hour time-weighted average of 85 decibels; providing workers with initial and annual audiograms; notifying workers of a loss in hearing based on comparing audiograms; maintaining records of workplace noise exposure and workers' audiograms; and allowing workers access to materials and records required by the Standard.

OSHA has a particular interest in comments on the following issues:

• Whether the proposed information collection requirements are necessary for the proper performance of the agency's functions to protect workers, including whether the information is useful;

• The accuracy of OSHA's estimate of the burden (time and costs) of the information collection requirements, including the validity of the methodology and assumptions used;

• The quality, utility, and clarity of the information collected; and

• Ways to minimize the burden on employers who must comply; for example, by using automated or other technological information, and transmission techniques.

OSHA is requesting that OMB extend the approval of the information collection requirements contained in Occupational Exposure to Noise Standard. The agency is requesting an adjustment increase in burden hours from 2,368,281 hours to 2,443,146 hours, a difference of 74,865 hours. The adjustment increase in the burden hours is due to an increase in the number of establishments going from 283,524 to 285,510 and the increase in the number of employees exposed above 85 dBA going from 3,802,698 to 3,935,792.

OSHA will summarize the comments submitted in response to this notice and will include this summary in the request to OMB to extend the approval of the information collection requirements.

Type of Review: Extension of a currently approved collection.

Title: Occupational Exposure to Noise Standard (29 CFR 1910.95).

OMB Control Number: 1218-0048.

Affected Public: Business or other for-profits.

Number of Respondents: 285,510.

Number of Responses: 17,424,368.

Frequency of Responses: On occasion.

Average Time per Response: Varies.

Estimated Total Burden Hours: 2,443,146.

Estimated Cost (Operation and Maintenance): $43,851,245.

You may submit comments in response to this document as follows: (1) electronically at https://www.regulations.gov, which is the Federal eRulemaking Portal; or (2) by facsimile (fax), if your comments, including attachments, are not longer than 10 pages you may fax them to the OSHA Docket Office at (202) 693-1648. All comments, attachments, and other material must identify the agency name and the OSHA docket number for the ICR (OSHA-2010-0017). You may supplement electronic submission by uploading document files electronically.

Comments and submissions are posted without change at https://www.regulations.gov. Therefore, OSHA cautions commenters about submitting personal information such as social security numbers and dates of birth. Although all submissions are listed in the https://www.regulations.gov index, some information ( e.g., copyrighted material) is not publicly available to read or download from this website. All submissions, including copyrighted material, are available for inspection and copying at the OSHA Docket Office. Information on using the https://www.regulations.gov website to submit comments and access the docket is available at the website's “User Tips” link. Contact the OSHA Docket Office at (202) 693-2350, (TTY (877) 889-5627) for information about materials not available from the website, and for assistance in using the internet to locate docket submissions.

Amanda Wood Laihow, Acting Assistant Secretary of Labor for Occupational Safety and Health, directed the preparation of this notice. The authority for this notice is the Paperwork Reduction Act of 1995 (44 U.S.C. 3506 et seq. ) and Secretary of Labor's Order No. 8-2020 (85 FR 58393).